Collegium Pharmaceutical
COLL
Lantheus
LNTH
SilverCrest Metals
SILV
Cars.com
CARS
Hutchmed (China)
HCM
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 151.56%4.14M | 63.08%-7.12M | 60.28%-16.17M | 332.55%5.95M | 210.93%5.21M | -168.56%-8.04M | 36.68%-19.29M | 34.72%-40.71M | -12.04%-2.56M | 78.10%-4.69M |
Net income from continuing operations | 27.09%-23.93M | 28.16%-27.59M | 78.29%-99.81M | 75.33%-7.51M | 47.17%-21.06M | 29.44%-32.83M | 88.80%-38.41M | -273.32%-459.65M | 11.93%-30.43M | -277.19%-39.87M |
Operating gains losses | ---- | ---- | ---9.27M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -1.67%10.64M | -10.72%10.39M | -2.62%45.16M | -2.77%11.31M | -1.74%11.4M | -6.51%10.82M | 0.55%11.64M | 8.85%46.38M | -0.11%11.63M | 3.13%11.6M |
Deferred tax | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 34.82%-4M | -103.91%-138K | --0 |
Other non cash items | -4.66%1.57M | 10.80%1.72M | 30.22%6.98M | 14.13%1.73M | 57.97%2.04M | 25.55%1.65M | 25.89%1.56M | 113.13%5.36M | 126.61%1.52M | 101.92%1.29M |
Change In working capital | 239.00%4.74M | 23.96%-6.35M | -1,648.07%-19.96M | -394.10%-14.66M | 47.31%6.45M | -126.24%-3.41M | 46.28%-8.35M | 85.44%-1.14M | 31.25%-2.97M | 146.40%4.38M |
-Change in receivables | 152.99%2.49M | -102.27%-9K | -124.53%-1.01M | 14.54%-2.15M | -103.78%-243K | 146.24%985K | -82.95%396K | 134.71%4.11M | 58.76%-2.51M | 189.42%6.42M |
-Change in payables and accrued expense | 383.05%6.16M | 49.99%-6.71M | -1,076.16%-12.57M | -79.16%993K | 75.87%2.02M | -117.80%-2.18M | 20.46%-13.41M | 129.15%1.29M | 143.54%4.77M | 452.15%1.15M |
-Change in other current assets | 790.48%1.68M | 364.16%3.62M | 41.89%-2.61M | -68.75%-3.33M | 186.85%1.9M | -51.41%189K | -92.69%-1.37M | -237.58%-4.48M | -196.24%-1.97M | -626.44%-2.19M |
-Change in other current liabilities | -581.68%-631K | 126.79%303K | -137.31%-607K | 27.30%-293K | -72.60%686K | 155.98%131K | -371.25%-1.13M | 1,634.91%1.63M | -142.83%-403K | 357.61%2.5M |
-Change in other working capital | -95.94%-4.97M | -149.70%-3.56M | 13.83%-3.17M | -247.05%-9.88M | 159.57%2.09M | -192.72%-2.54M | 11,650.00%7.16M | -137.41%-3.68M | 10.27%-2.85M | -155.09%-3.51M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 151.56%4.14M | 63.08%-7.12M | 60.28%-16.17M | 332.55%5.95M | 210.93%5.21M | -168.56%-8.04M | 36.68%-19.29M | 34.72%-40.71M | -12.04%-2.56M | 78.10%-4.69M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -494.92%-19.55M | 338.23%8.05M | -780.31%-63.63M | -2,106.96%-53.25M | -94.24%-3.71M | -101.35%-3.29M | -165.49%-3.38M | 97.26%-7.23M | -353.57%-2.41M | -365.05%-1.91M |
Capital expenditure reported | 68.56%-691K | 50.32%-1.24M | -47.32%-7.55M | 51.47%-1.07M | -25.58%-1.78M | -199.86%-2.2M | -226.37%-2.5M | -367.43%-5.12M | -363.10%-2.21M | -438.02%-1.42M |
Net PPE purchase and sale | 67.10%-358K | 18.70%-713K | -134.44%-4.94M | -407.35%-1.04M | -290.12%-1.94M | -21.02%-1.09M | -73.32%-877K | 16.50%-2.11M | 8.93%-204K | 31.49%-496K |
Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net investment purchase and sale | ---18.5M | --10M | ---51.15M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -494.92%-19.55M | 338.23%8.05M | -780.31%-63.63M | -2,106.96%-53.25M | -94.24%-3.71M | -101.35%-3.29M | -165.49%-3.38M | 97.26%-7.23M | -353.57%-2.41M | -365.05%-1.91M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -98.28%11K | -53.58%2.07M | -1,856.78%-55.57M | 618.66%3M | -4,061.61%-63.66M | 273.24%641K | 195.16%4.45M | -98.77%3.16M | -84.44%418K | -40.04%1.61M |
Net issuance payments of debt | ---- | ---- | ---65.81M | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
Proceeds from stock option exercised by employees | -98.28%11K | -53.58%2.07M | 112.30%10.6M | 618.66%3M | 55.57%2.5M | -56.04%641K | 195.16%4.45M | -62.48%4.99M | -84.44%418K | -40.04%1.61M |
Net other financing activities | ---- | ---- | 80.58%-355K | --0 | ---- | ---- | ---- | 95.74%-1.83M | --0 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -98.28%11K | -53.58%2.07M | -1,856.78%-55.57M | 618.66%3M | -4,061.61%-63.66M | 273.24%641K | 195.16%4.45M | -98.77%3.16M | -84.44%418K | -40.04%1.61M |
Net cash flow | ||||||||||
Beginning cash position | -37.69%188.71M | -42.16%185.72M | -12.24%321.08M | -29.36%230.02M | -11.63%292.19M | -9.76%302.87M | -12.24%321.08M | -15.68%365.85M | -11.02%325.64M | -13.90%330.63M |
Current changes in cash | -44.10%-15.39M | 116.42%2.99M | -202.36%-135.37M | -872.75%-44.3M | -1,144.40%-62.17M | -113.87%-10.68M | 39.74%-18.21M | 34.19%-44.77M | -3,430.23%-4.55M | 72.28%-5M |
End cash Position | -40.68%173.32M | -37.69%188.71M | -42.16%185.72M | -42.16%185.72M | -29.36%230.02M | -11.63%292.19M | -9.76%302.87M | -12.24%321.08M | -12.24%321.08M | -11.02%325.64M |
Free cash flow | 127.33%3.1M | 59.96%-9.08M | 40.23%-28.65M | 177.31%3.84M | 122.61%1.49M | -144.84%-11.32M | 28.58%-22.66M | 27.34%-47.93M | -66.57%-4.97M | 70.53%-6.6M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |